1 | When two worlds collide: Adenosquamous histology 2024-05-07 |
Play |
2 | KRAS in NSCLC: Beyond G12C 2024-04-30 |
Play |
3 | FDA Approval: Adjuvant Alectinib for Resected NSCLC 2024-04-18 |
Play |
4 | IASLC DEI Initiative Global Member Survey 2024-04-16 |
Play |
5 | FDA Approval: FLAURA2, First Line Osimertinib Plus Chemotherapy for EGFR NSCLC 2024-04-02 |
Play |
6 | ELCC 2024 Highlights 2024-03-28 |
Play |
7 | Emerging Agents In Small Cell Lung Cancer 2024-03-19 |
Play |
8 | Radiopharmaceuticals and Lung Cancer 2024-03-05 |
Play |
9 | FDA Approval: 1L Amivantamab plus Chemotherapy for EGFR Exon 20 NSCLC 2024-03-01 |
Play |
10 | Seminal Trials: Nivolumab Phase I Trial & Immunotherapy for NSCLC 2024-02-29 |
Play |